实用癌症杂志
實用癌癥雜誌
실용암증잡지
THE PRACTICAL JOURNAL OF CANCER
2014年
11期
1420-1421,1435
,共3页
韩毓%曲兴龙%张怡%王炳%柴宇啸
韓毓%麯興龍%張怡%王炳%柴宇嘯
한육%곡흥룡%장이%왕병%시우소
肢体软组织肉瘤%肿瘤屏障切除%血管切除%人工血管重建
肢體軟組織肉瘤%腫瘤屏障切除%血管切除%人工血管重建
지체연조직육류%종류병장절제%혈관절제%인공혈관중건
Extremity soft tissue sarcomas%Tumor resection%Vascular resection%Artificial blood vessel reconstruction
目的:探讨肢体软组织肉瘤及受累的大血管切除联合人工血管重建的临床疗效。方法对19例累及肢体重要血管的软组织肉瘤患者行肿瘤屏障切除联合人工血管手术,8例同时重建动脉和静脉,4例重建动脉,7例重建静脉,均采用人工血管置换。观察术后血管通畅及肿瘤复发情况。结果无1例出现重建血管感染,伤口均一期愈合。全部患者随访3~32个月,平均18个月。随访期间重建动、静脉通畅率分别为100%和46%,未见肿瘤复发。结论肢体软组织肉瘤累及重要血管进行切除联合人工血管重建安全可靠,能提高切除率,降低肿瘤复发率。
目的:探討肢體軟組織肉瘤及受纍的大血管切除聯閤人工血管重建的臨床療效。方法對19例纍及肢體重要血管的軟組織肉瘤患者行腫瘤屏障切除聯閤人工血管手術,8例同時重建動脈和靜脈,4例重建動脈,7例重建靜脈,均採用人工血管置換。觀察術後血管通暢及腫瘤複髮情況。結果無1例齣現重建血管感染,傷口均一期愈閤。全部患者隨訪3~32箇月,平均18箇月。隨訪期間重建動、靜脈通暢率分彆為100%和46%,未見腫瘤複髮。結論肢體軟組織肉瘤纍及重要血管進行切除聯閤人工血管重建安全可靠,能提高切除率,降低腫瘤複髮率。
목적:탐토지체연조직육류급수루적대혈관절제연합인공혈관중건적림상료효。방법대19례루급지체중요혈관적연조직육류환자행종류병장절제연합인공혈관수술,8례동시중건동맥화정맥,4례중건동맥,7례중건정맥,균채용인공혈관치환。관찰술후혈관통창급종류복발정황。결과무1례출현중건혈관감염,상구균일기유합。전부환자수방3~32개월,평균18개월。수방기간중건동、정맥통창솔분별위100%화46%,미견종류복발。결론지체연조직육류루급중요혈관진행절제연합인공혈관중건안전가고,능제고절제솔,강저종류복발솔。
Objective To explore the clinical efficacy of major vascular resection and vascular prosthesis in the major vessels invaded by soft tissue sarcomas of extremity .Methods 19 patients with extremity soft tissue sarcomas invading major ves-sels underwent tumor resection and artificial vascular implantation .8 patients received combined reconstruction of arteries and veins,4 patients received artery reconstruction ,and 7 patients received venous reconstruction ,all using artificial vascular replace-ment .The vascular patency and tumor recurrence were observed after operation .Results None of the patients had revasculariza-tion infection and the wound all healed .19 patients were followed up for 3-32 months,and the average was 18 months.The arteries patency rate was 100%and the vessels patency rate was 46%,no tumor recurrence was found .Conclusion For the extremity soft tissue sarcoma patients with major vessels involvement ,tumor resection with artificial vessel implantation is safe and effective, and it can reduce recurrence and improve the tumor resection rate .